DENALI ADVISORS LLC - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 65 filers reported holding IRADIMED CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DENALI ADVISORS LLC ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$261,783
-7.1%
5,9000.0%0.09%
-7.1%
Q2 2023$281,666
+1241.3%
5,900
+637.5%
0.10%
+1550.0%
Q1 2021$21,000
+16.7%
8000.0%0.01%
+100.0%
Q4 2020$18,000
+5.9%
8000.0%0.00%0.0%
Q3 2020$17,000
-10.5%
8000.0%0.00%
-25.0%
Q2 2020$19,000
+11.8%
8000.0%0.00%0.0%
Q1 2020$17,0008000.00%
Other shareholders
IRADIMED CORP shareholders Q2 2020
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 781,766$22,116,0003.84%
Soleus Capital Management, L.P. 745,004$21,076,1633.02%
RK Capital 366,000$10,354,1402.45%
Capital Impact Advisors, LLC 20,370$576,2670.56%
Ranger Investment Management 198,635$5,619,3840.42%
Bares Capital Management 271,300$7,675,0770.29%
Hillsdale Investment Management Inc. 108,500$3,069,4650.26%
CORNERCAP INVESTMENT COUNSEL INC 36,790$1,040,7890.18%
RICE HALL JAMES & ASSOCIATES, LLC 73,238$2,071,9030.12%
CIM, LLC 9,014$318,1490.06%
View complete list of IRADIMED CORP shareholders